JP2004529119A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004529119A5 JP2004529119A5 JP2002571497A JP2002571497A JP2004529119A5 JP 2004529119 A5 JP2004529119 A5 JP 2004529119A5 JP 2002571497 A JP2002571497 A JP 2002571497A JP 2002571497 A JP2002571497 A JP 2002571497A JP 2004529119 A5 JP2004529119 A5 JP 2004529119A5
- Authority
- JP
- Japan
- Prior art keywords
- pyridin
- pyrazolo
- pyrimidinyl
- cyclopentylamino
- amine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 125000000217 alkyl group Chemical group 0.000 claims 6
- 125000000753 cycloalkyl group Chemical group 0.000 claims 6
- -1 (4- {7- (cyclopentylamino) -3- [2- (cyclopentylamino) -4-pyrimidinyl] -pyrazolo [1,5-a] pyridin-2-yl} phenoxy) ethyl Chemical group 0.000 claims 5
- 125000003342 alkenyl group Chemical group 0.000 claims 5
- 125000001475 halogen functional group Chemical group 0.000 claims 5
- 125000000392 cycloalkenyl group Chemical group 0.000 claims 4
- 125000006312 cyclopentyl amino group Chemical group [H]N(*)C1([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 claims 4
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 claims 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Natural products CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims 2
- 125000000304 alkynyl group Chemical group 0.000 claims 2
- 125000005336 allyloxy group Chemical group 0.000 claims 2
- 125000003118 aryl group Chemical group 0.000 claims 2
- 230000035790 physiological processes and functions Effects 0.000 claims 2
- CTLCJJPQDYDSQF-UHFFFAOYSA-N pyrazolo[1,5-a]pyridin-7-amine Chemical compound NC1=CC=CC2=CC=NN12 CTLCJJPQDYDSQF-UHFFFAOYSA-N 0.000 claims 2
- 125000004527 pyrimidin-4-yl group Chemical group N1=CN=C(C=C1)* 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 239000012453 solvate Substances 0.000 claims 2
- 125000006704 (C5-C6) cycloalkyl group Chemical group 0.000 claims 1
- QWUWMCYKGHVNAV-UHFFFAOYSA-N 1,2-dihydrostilbene Chemical group C=1C=CC=CC=1CCC1=CC=CC=C1 QWUWMCYKGHVNAV-UHFFFAOYSA-N 0.000 claims 1
- QWLYSDRFTNRBBK-UHFFFAOYSA-N 1-[4-[[3-[2-(cyclopentylamino)pyrimidin-4-yl]-2-(4-methoxyphenyl)pyrazolo[1,5-a]pyridin-7-yl]amino]butyl]-3-(4-methylphenyl)sulfonylurea Chemical compound C1=CC(OC)=CC=C1C1=NN(C(NCCCCNC(=O)NS(=O)(=O)C=2C=CC(C)=CC=2)=CC=C2)C2=C1C1=CC=NC(NC2CCCC2)=N1 QWLYSDRFTNRBBK-UHFFFAOYSA-N 0.000 claims 1
- RADJASMYJQAUJI-UHFFFAOYSA-N 2-(2-bromophenyl)-n-cyclopentyl-3-[2-(cyclopentylamino)pyrimidin-4-yl]pyrazolo[1,5-a]pyridin-7-amine Chemical compound BrC1=CC=CC=C1C1=NN(C(NC2CCCC2)=CC=C2)C2=C1C1=CC=NC(NC2CCCC2)=N1 RADJASMYJQAUJI-UHFFFAOYSA-N 0.000 claims 1
- IKLFKJPFQIXZCB-UHFFFAOYSA-N 2-(3-amino-4-chlorophenyl)-n-cyclopentyl-3-[2-(cyclopentylamino)pyrimidin-4-yl]pyrazolo[1,5-a]pyridin-7-amine Chemical compound C1=C(Cl)C(N)=CC(C=2C(=C3C=CC=C(NC4CCCC4)N3N=2)C=2N=C(NC3CCCC3)N=CC=2)=C1 IKLFKJPFQIXZCB-UHFFFAOYSA-N 0.000 claims 1
- CLOLNRNDHYJZSS-UHFFFAOYSA-N 2-(3-aminophenyl)-n-cyclopentyl-3-[2-(cyclopentylamino)pyrimidin-4-yl]pyrazolo[1,5-a]pyridin-7-amine Chemical compound NC1=CC=CC(C=2C(=C3C=CC=C(NC4CCCC4)N3N=2)C=2N=C(NC3CCCC3)N=CC=2)=C1 CLOLNRNDHYJZSS-UHFFFAOYSA-N 0.000 claims 1
- LZKPXAYLIVWHIR-UHFFFAOYSA-N 2-(3-azidophenyl)-n-cyclopentyl-3-[2-(cyclopentylamino)pyrimidin-4-yl]pyrazolo[1,5-a]pyridin-7-amine Chemical compound [N-]=[N+]=NC1=CC=CC(C=2C(=C3C=CC=C(NC4CCCC4)N3N=2)C=2N=C(NC3CCCC3)N=CC=2)=C1 LZKPXAYLIVWHIR-UHFFFAOYSA-N 0.000 claims 1
- AZQWIDZJMCVVCL-UHFFFAOYSA-N 2-(3-bromo-4-chlorophenyl)-n-cyclopentyl-3-[2-(cyclopentylamino)pyrimidin-4-yl]pyrazolo[1,5-a]pyridin-7-amine Chemical compound C1=C(Br)C(Cl)=CC=C1C1=NN(C(NC2CCCC2)=CC=C2)C2=C1C1=CC=NC(NC2CCCC2)=N1 AZQWIDZJMCVVCL-UHFFFAOYSA-N 0.000 claims 1
- BZZXNPCNQJMBCD-UHFFFAOYSA-N 2-(3-bromo-4-methoxyphenyl)-n-cyclopentyl-3-[2-(cyclopentylamino)pyrimidin-4-yl]pyrazolo[1,5-a]pyridin-7-amine Chemical compound C1=C(Br)C(OC)=CC=C1C1=NN(C(NC2CCCC2)=CC=C2)C2=C1C1=CC=NC(NC2CCCC2)=N1 BZZXNPCNQJMBCD-UHFFFAOYSA-N 0.000 claims 1
- HFEYWTFIOJKIJG-UHFFFAOYSA-N 2-(3-bromophenyl)-3-[2-(cyclopentylamino)pyrimidin-4-yl]-n-cyclopropylpyrazolo[1,5-a]pyridin-7-amine Chemical compound BrC1=CC=CC(C=2C(=C3C=CC=C(NC4CC4)N3N=2)C=2N=C(NC3CCCC3)N=CC=2)=C1 HFEYWTFIOJKIJG-UHFFFAOYSA-N 0.000 claims 1
- BPAMNDQCSLFBDM-UHFFFAOYSA-N 2-(3-bromophenyl)-n-cyclopentyl-3-[2-(cyclopentylamino)pyrimidin-4-yl]pyrazolo[1,5-a]pyridin-7-amine Chemical compound BrC1=CC=CC(C=2C(=C3C=CC=C(NC4CCCC4)N3N=2)C=2N=C(NC3CCCC3)N=CC=2)=C1 BPAMNDQCSLFBDM-UHFFFAOYSA-N 0.000 claims 1
- BRORWJUKGAHUPQ-UHFFFAOYSA-N 2-(3-bromophenyl)-n-cyclopentyl-3-[2-(cyclopropylamino)pyrimidin-4-yl]pyrazolo[1,5-a]pyridin-7-amine Chemical compound BrC1=CC=CC(C=2C(=C3C=CC=C(NC4CCCC4)N3N=2)C=2N=C(NC3CC3)N=CC=2)=C1 BRORWJUKGAHUPQ-UHFFFAOYSA-N 0.000 claims 1
- LYAAIUHFSVIZHL-UHFFFAOYSA-N 2-(3-bromophenyl)-n-cyclopropyl-3-[2-(cyclopropylamino)pyrimidin-4-yl]pyrazolo[1,5-a]pyridin-7-amine Chemical compound BrC1=CC=CC(C=2C(=C3C=CC=C(NC4CC4)N3N=2)C=2N=C(NC3CC3)N=CC=2)=C1 LYAAIUHFSVIZHL-UHFFFAOYSA-N 0.000 claims 1
- LZHBQDAZVHGFHJ-UHFFFAOYSA-N 2-(3-chlorophenyl)-3-[2-(cyclopentylamino)pyrimidin-4-yl]-n-(2-methoxyethyl)pyrazolo[1,5-a]pyridin-7-amine Chemical compound N=1N2C(NCCOC)=CC=CC2=C(C=2N=C(NC3CCCC3)N=CC=2)C=1C1=CC=CC(Cl)=C1 LZHBQDAZVHGFHJ-UHFFFAOYSA-N 0.000 claims 1
- YIBNLVFHWFNOQI-UHFFFAOYSA-N 2-(3-chlorophenyl)-3-[2-(cyclopentylamino)pyrimidin-4-yl]-n-cyclopropylpyrazolo[1,5-a]pyridin-7-amine Chemical compound ClC1=CC=CC(C=2C(=C3C=CC=C(NC4CC4)N3N=2)C=2N=C(NC3CCCC3)N=CC=2)=C1 YIBNLVFHWFNOQI-UHFFFAOYSA-N 0.000 claims 1
- NLNUPJVGCWUSNO-UHFFFAOYSA-N 2-(3-chlorophenyl)-n-cyclopentyl-3-[2-(cyclopentylamino)pyrimidin-4-yl]pyrazolo[1,5-a]pyridin-7-amine Chemical compound ClC1=CC=CC(C=2C(=C3C=CC=C(NC4CCCC4)N3N=2)C=2N=C(NC3CCCC3)N=CC=2)=C1 NLNUPJVGCWUSNO-UHFFFAOYSA-N 0.000 claims 1
- HTAHLXOEHLWANV-UHFFFAOYSA-N 2-(3-chlorophenyl)-n-cyclopentyl-3-[2-(cyclopropylamino)pyrimidin-4-yl]pyrazolo[1,5-a]pyridin-7-amine Chemical compound ClC1=CC=CC(C=2C(=C3C=CC=C(NC4CCCC4)N3N=2)C=2N=C(NC3CC3)N=CC=2)=C1 HTAHLXOEHLWANV-UHFFFAOYSA-N 0.000 claims 1
- ZWJRQGJBCWTXAI-UHFFFAOYSA-N 2-(3-chlorophenyl)-n-cyclopropyl-3-[2-(cyclopropylamino)pyrimidin-4-yl]pyrazolo[1,5-a]pyridin-7-amine Chemical compound ClC1=CC=CC(C=2C(=C3C=CC=C(NC4CC4)N3N=2)C=2N=C(NC3CC3)N=CC=2)=C1 ZWJRQGJBCWTXAI-UHFFFAOYSA-N 0.000 claims 1
- GCHDTEVSZUGMOM-UHFFFAOYSA-N 2-(4-aminophenyl)-n-butyl-3-[2-(butylamino)pyrimidin-4-yl]pyrazolo[1,5-a]pyridin-7-amine Chemical compound CCCCNC1=NC=CC(C2=C3C=CC=C(NCCCC)N3N=C2C=2C=CC(N)=CC=2)=N1 GCHDTEVSZUGMOM-UHFFFAOYSA-N 0.000 claims 1
- QDYLEYFQUPNZPC-UHFFFAOYSA-N 2-(4-anilinophenyl)-n-butyl-3-[2-(butylamino)pyrimidin-4-yl]-n-phenylpyrazolo[1,5-a]pyridin-7-amine Chemical compound CCCCNC1=NC=CC(C2=C3C=CC=C(N3N=C2C=2C=CC(NC=3C=CC=CC=3)=CC=2)N(CCCC)C=2C=CC=CC=2)=N1 QDYLEYFQUPNZPC-UHFFFAOYSA-N 0.000 claims 1
- MCYNAHONGQXOIV-UHFFFAOYSA-N 2-(4-anilinophenyl)-n-butyl-3-[2-(butylamino)pyrimidin-4-yl]pyrazolo[1,5-a]pyridin-7-amine Chemical compound CCCCNC1=NC=CC(C2=C3C=CC=C(NCCCC)N3N=C2C=2C=CC(NC=3C=CC=CC=3)=CC=2)=N1 MCYNAHONGQXOIV-UHFFFAOYSA-N 0.000 claims 1
- BRXUKKJUJGQKCF-UHFFFAOYSA-N 2-(4-butoxyphenyl)-n-cyclopentyl-3-[2-(cyclopentylamino)pyrimidin-4-yl]pyrazolo[1,5-a]pyridin-7-amine Chemical compound C1=CC(OCCCC)=CC=C1C1=NN(C(NC2CCCC2)=CC=C2)C2=C1C1=CC=NC(NC2CCCC2)=N1 BRXUKKJUJGQKCF-UHFFFAOYSA-N 0.000 claims 1
- RJKZCZWMDVDIEG-UHFFFAOYSA-N 2-[4-(benzylamino)phenyl]-n-butyl-3-[2-(butylamino)pyrimidin-4-yl]pyrazolo[1,5-a]pyridin-7-amine Chemical compound CCCCNC1=NC=CC(C2=C3C=CC=C(NCCCC)N3N=C2C=2C=CC(NCC=3C=CC=CC=3)=CC=2)=N1 RJKZCZWMDVDIEG-UHFFFAOYSA-N 0.000 claims 1
- FSYBMNDKWAAPFI-UHFFFAOYSA-N 2-[4-(cyclobutylmethoxy)phenyl]-n-cyclopentyl-3-[2-(cyclopentylamino)pyrimidin-4-yl]pyrazolo[1,5-a]pyridin-7-amine Chemical compound C1CCC1COC(C=C1)=CC=C1C(C(=C1C=CC=2)C=3N=C(NC4CCCC4)N=CC=3)=NN1C=2NC1CCCC1 FSYBMNDKWAAPFI-UHFFFAOYSA-N 0.000 claims 1
- UENOPHWRHNSCII-UHFFFAOYSA-N 2-[4-[[3-[2-(cyclopentylamino)pyrimidin-4-yl]-2-(4-methoxyphenyl)pyrazolo[1,5-a]pyridin-7-yl]amino]butyl]guanidine Chemical compound C1=CC(OC)=CC=C1C1=NN(C(NCCCCNC(N)=N)=CC=C2)C2=C1C1=CC=NC(NC2CCCC2)=N1 UENOPHWRHNSCII-UHFFFAOYSA-N 0.000 claims 1
- VQMBTDRVJJEGMV-UHFFFAOYSA-N 2-[4-[bis(cyclopropylmethyl)amino]phenyl]-n-butyl-3-[2-(butylamino)pyrimidin-4-yl]pyrazolo[1,5-a]pyridin-7-amine Chemical compound CCCCNC1=NC=CC(C2=C3C=CC=C(NCCCC)N3N=C2C=2C=CC(=CC=2)N(CC2CC2)CC2CC2)=N1 VQMBTDRVJJEGMV-UHFFFAOYSA-N 0.000 claims 1
- YYFPOOZYHPFEKB-UHFFFAOYSA-N 2-[[3-[2-(cyclopentylamino)pyrimidin-4-yl]-2-(4-methoxyphenyl)pyrazolo[1,5-a]pyridin-7-yl]amino]-1-pyrrolidin-1-ylethanone Chemical compound C1=CC(OC)=CC=C1C1=NN(C(NCC(=O)N2CCCC2)=CC=C2)C2=C1C1=CC=NC(NC2CCCC2)=N1 YYFPOOZYHPFEKB-UHFFFAOYSA-N 0.000 claims 1
- 125000004200 2-methoxyethyl group Chemical group [H]C([H])([H])OC([H])([H])C([H])([H])* 0.000 claims 1
- DOPXOLYXUQQAGU-UHFFFAOYSA-N 3-(2-aminopyrimidin-4-yl)-2-(3-bromophenyl)-n-cyclopentylpyrazolo[1,5-a]pyridin-7-amine Chemical compound NC1=NC=CC(C2=C3C=CC=C(NC4CCCC4)N3N=C2C=2C=C(Br)C=CC=2)=N1 DOPXOLYXUQQAGU-UHFFFAOYSA-N 0.000 claims 1
- YYFSVZHWEACRRX-UHFFFAOYSA-N 3-[2-(cyclopentylamino)pyrimidin-4-yl]-2-(3-fluorophenyl)-n-(2-methoxyethyl)pyrazolo[1,5-a]pyridin-7-amine Chemical compound N=1N2C(NCCOC)=CC=CC2=C(C=2N=C(NC3CCCC3)N=CC=2)C=1C1=CC=CC(F)=C1 YYFSVZHWEACRRX-UHFFFAOYSA-N 0.000 claims 1
- QYGNAMDJSFPVGI-UHFFFAOYSA-N 3-[2-(cyclopentylamino)pyrimidin-4-yl]-2-(3-methoxyphenyl)-n,n-dimethylpyrazolo[1,5-a]pyridin-7-amine Chemical compound COC1=CC=CC(C=2C(=C3C=CC=C(N3N=2)N(C)C)C=2N=C(NC3CCCC3)N=CC=2)=C1 QYGNAMDJSFPVGI-UHFFFAOYSA-N 0.000 claims 1
- WGCAOYVEHYBUCT-UHFFFAOYSA-N 3-[2-(cyclopentylamino)pyrimidin-4-yl]-2-(3-methoxyphenyl)-n-propan-2-ylpyrazolo[1,5-a]pyridin-7-amine Chemical compound COC1=CC=CC(C=2C(=C3C=CC=C(NC(C)C)N3N=2)C=2N=C(NC3CCCC3)N=CC=2)=C1 WGCAOYVEHYBUCT-UHFFFAOYSA-N 0.000 claims 1
- BQTVXODZORGWDG-UHFFFAOYSA-N 3-[2-(cyclopentylamino)pyrimidin-4-yl]-2-(3-methylphenyl)-n-propan-2-ylpyrazolo[1,5-a]pyridin-7-amine Chemical compound N=1N2C(NC(C)C)=CC=CC2=C(C=2N=C(NC3CCCC3)N=CC=2)C=1C1=CC=CC(C)=C1 BQTVXODZORGWDG-UHFFFAOYSA-N 0.000 claims 1
- HZEXXIRPHHCCLZ-UHFFFAOYSA-N 3-[2-(cyclopentylamino)pyrimidin-4-yl]-2-(4-methoxyphenyl)-n-(2-morpholin-4-ylethyl)pyrazolo[1,5-a]pyridin-7-amine Chemical compound C1=CC(OC)=CC=C1C1=NN(C(NCCN2CCOCC2)=CC=C2)C2=C1C1=CC=NC(NC2CCCC2)=N1 HZEXXIRPHHCCLZ-UHFFFAOYSA-N 0.000 claims 1
- HISQMDKDLBLMKM-UHFFFAOYSA-N 3-[2-(cyclopentylamino)pyrimidin-4-yl]-2-(4-methoxyphenyl)pyrazolo[1,5-a]pyridin-7-amine Chemical compound C1=CC(OC)=CC=C1C1=NN(C(N)=CC=C2)C2=C1C1=CC=NC(NC2CCCC2)=N1 HISQMDKDLBLMKM-UHFFFAOYSA-N 0.000 claims 1
- QMVMSRWJIQROTI-UHFFFAOYSA-N 3-[2-(cyclopentylamino)pyrimidin-4-yl]-n-cyclopropyl-2-(3-fluorophenyl)pyrazolo[1,5-a]pyridin-7-amine Chemical compound FC1=CC=CC(C=2C(=C3C=CC=C(NC4CC4)N3N=2)C=2N=C(NC3CCCC3)N=CC=2)=C1 QMVMSRWJIQROTI-UHFFFAOYSA-N 0.000 claims 1
- NSNVVQOTZRQGMG-UHFFFAOYSA-N 3-[2-(cyclopentylamino)pyrimidin-4-yl]-n-cyclopropyl-2-(4-methoxyphenyl)pyrazolo[1,5-a]pyridin-7-amine Chemical compound C1=CC(OC)=CC=C1C1=NN(C(NC2CC2)=CC=C2)C2=C1C1=CC=NC(NC2CCCC2)=N1 NSNVVQOTZRQGMG-UHFFFAOYSA-N 0.000 claims 1
- KSSZHVRVJVWUGH-UHFFFAOYSA-N 3-[2-(cyclopentylamino)pyrimidin-4-yl]-n-cyclopropyl-2-[4-(cyclopropylmethoxy)phenyl]pyrazolo[1,5-a]pyridin-7-amine Chemical compound C1CC1COC(C=C1)=CC=C1C(C(=C1C=CC=2)C=3N=C(NC4CCCC4)N=CC=3)=NN1C=2NC1CC1 KSSZHVRVJVWUGH-UHFFFAOYSA-N 0.000 claims 1
- UYJVTDSQXZGSHB-UHFFFAOYSA-N 3-[2-(cyclopropylamino)pyrimidin-4-yl]-2-(4-methoxyphenyl)-n-(2-morpholin-4-ylethyl)pyrazolo[1,5-a]pyridin-7-amine Chemical compound C1=CC(OC)=CC=C1C1=NN(C(NCCN2CCOCC2)=CC=C2)C2=C1C1=CC=NC(NC2CC2)=N1 UYJVTDSQXZGSHB-UHFFFAOYSA-N 0.000 claims 1
- RVOLAJPEIJSJIP-UHFFFAOYSA-N 3-[2-(cyclopropylamino)pyrimidin-4-yl]-n-(2-methoxyethyl)-2-(4-methoxyphenyl)pyrazolo[1,5-a]pyridin-7-amine Chemical compound N=1N2C(NCCOC)=CC=CC2=C(C=2N=C(NC3CC3)N=CC=2)C=1C1=CC=C(OC)C=C1 RVOLAJPEIJSJIP-UHFFFAOYSA-N 0.000 claims 1
- WGEYMTPFWCAKOC-UHFFFAOYSA-N 3-[7-(cyclopentylamino)-3-[2-(cyclopentylamino)pyrimidin-4-yl]pyrazolo[1,5-a]pyridin-2-yl]benzamide Chemical compound NC(=O)C1=CC=CC(C=2C(=C3C=CC=C(NC4CCCC4)N3N=2)C=2N=C(NC3CCCC3)N=CC=2)=C1 WGEYMTPFWCAKOC-UHFFFAOYSA-N 0.000 claims 1
- TWMBFFPRWBHQMZ-UHFFFAOYSA-N 3-[7-(cyclopentylamino)-3-[2-(cyclopentylamino)pyrimidin-4-yl]pyrazolo[1,5-a]pyridin-2-yl]benzoic acid Chemical compound OC(=O)C1=CC=CC(C=2C(=C3C=CC=C(NC4CCCC4)N3N=2)C=2N=C(NC3CCCC3)N=CC=2)=C1 TWMBFFPRWBHQMZ-UHFFFAOYSA-N 0.000 claims 1
- LWTKNKOXQOKNHQ-UHFFFAOYSA-N 3-[7-(cyclopentylamino)-3-[2-(cyclopentylamino)pyrimidin-4-yl]pyrazolo[1,5-a]pyridin-2-yl]benzonitrile Chemical compound N#CC1=CC=CC(C=2C(=C3C=CC=C(NC4CCCC4)N3N=2)C=2N=C(NC3CCCC3)N=CC=2)=C1 LWTKNKOXQOKNHQ-UHFFFAOYSA-N 0.000 claims 1
- OCBBEFAPAGBLDV-UHFFFAOYSA-N 3-[7-(cyclopentylamino)-3-[2-(cyclopentylamino)pyrimidin-4-yl]pyrazolo[1,5-a]pyridin-2-yl]phenol Chemical compound OC1=CC=CC(C=2C(=C3C=CC=C(NC4CCCC4)N3N=2)C=2N=C(NC3CCCC3)N=CC=2)=C1 OCBBEFAPAGBLDV-UHFFFAOYSA-N 0.000 claims 1
- 125000001541 3-thienyl group Chemical group S1C([H])=C([*])C([H])=C1[H] 0.000 claims 1
- WBDOSLTTZIURRR-UHFFFAOYSA-N 4-[2-(3-aminophenyl)-7-pyrrolidin-1-ylpyrazolo[1,5-a]pyridin-3-yl]-n-cyclopentylpyrimidin-2-amine Chemical compound NC1=CC=CC(C=2C(=C3C=CC=C(N3N=2)N2CCCC2)C=2N=C(NC3CCCC3)N=CC=2)=C1 WBDOSLTTZIURRR-UHFFFAOYSA-N 0.000 claims 1
- DUBQKOZKJQTPCG-UHFFFAOYSA-N 4-[2-(3-bromophenyl)-7-pyrrolidin-1-ylpyrazolo[1,5-a]pyridin-3-yl]-n-cyclopentylpyrimidin-2-amine Chemical compound BrC1=CC=CC(C=2C(=C3C=CC=C(N3N=2)N2CCCC2)C=2N=C(NC3CCCC3)N=CC=2)=C1 DUBQKOZKJQTPCG-UHFFFAOYSA-N 0.000 claims 1
- XWZGAKRBMROWPJ-UHFFFAOYSA-N 4-[2-(3-bromophenyl)-7-pyrrolidin-1-ylpyrazolo[1,5-a]pyridin-3-yl]pyrimidin-2-amine Chemical compound NC1=NC=CC(C2=C3C=CC=C(N3N=C2C=2C=C(Br)C=CC=2)N2CCCC2)=N1 XWZGAKRBMROWPJ-UHFFFAOYSA-N 0.000 claims 1
- CDOYIVPLMXHLON-UHFFFAOYSA-N 4-[2-(3-chlorophenyl)-7-morpholin-4-ylpyrazolo[1,5-a]pyridin-3-yl]-n-cyclopentylpyrimidin-2-amine Chemical compound ClC1=CC=CC(C=2C(=C3C=CC=C(N3N=2)N2CCOCC2)C=2N=C(NC3CCCC3)N=CC=2)=C1 CDOYIVPLMXHLON-UHFFFAOYSA-N 0.000 claims 1
- YZYKMRMDEPRYFE-UHFFFAOYSA-N 4-[2-(4-methoxyphenyl)-7-pyrrolidin-1-ylpyrazolo[1,5-a]pyridin-3-yl]pyrimidin-2-amine Chemical compound C1=CC(OC)=CC=C1C1=NN(C(=CC=C2)N3CCCC3)C2=C1C1=CC=NC(N)=N1 YZYKMRMDEPRYFE-UHFFFAOYSA-N 0.000 claims 1
- YMRBSQVPVTYLPC-UHFFFAOYSA-N 4-[3-(2-aminopyrimidin-4-yl)-7-pyrrolidin-1-ylpyrazolo[1,5-a]pyridin-2-yl]phenol Chemical compound NC1=NC=CC(C2=C3C=CC=C(N3N=C2C=2C=CC(O)=CC=2)N2CCCC2)=N1 YMRBSQVPVTYLPC-UHFFFAOYSA-N 0.000 claims 1
- OXZGCWROXDNAAC-UHFFFAOYSA-N 4-[3-[2-(cyclopentylamino)pyrimidin-4-yl]-7-(cyclopropylamino)pyrazolo[1,5-a]pyridin-2-yl]phenol Chemical compound C1=CC(O)=CC=C1C1=NN(C(NC2CC2)=CC=C2)C2=C1C1=CC=NC(NC2CCCC2)=N1 OXZGCWROXDNAAC-UHFFFAOYSA-N 0.000 claims 1
- ROZOPWJQDHFSMY-UHFFFAOYSA-N 4-[3-[2-(cyclopentylamino)pyrimidin-4-yl]-7-pyrrolidin-1-ylpyrazolo[1,5-a]pyridin-2-yl]phenol Chemical compound C1=CC(O)=CC=C1C1=NN(C(=CC=C2)N3CCCC3)C2=C1C1=CC=NC(NC2CCCC2)=N1 ROZOPWJQDHFSMY-UHFFFAOYSA-N 0.000 claims 1
- LWZUYXVMXCJBQD-UHFFFAOYSA-N 4-[4-[[3-[2-(cyclopentylamino)pyrimidin-4-yl]-2-(4-methoxyphenyl)pyrazolo[1,5-a]pyridin-7-yl]amino]butylamino]-4-oxobutanoic acid Chemical compound C1=CC(OC)=CC=C1C1=NN(C(NCCCCNC(=O)CCC(O)=O)=CC=C2)C2=C1C1=CC=NC(NC2CCCC2)=N1 LWZUYXVMXCJBQD-UHFFFAOYSA-N 0.000 claims 1
- IUEPWZMCLQDBOR-UHFFFAOYSA-N 4-[7-(cyclopentylamino)-3-[2-(cyclopentylamino)pyrimidin-4-yl]pyrazolo[1,5-a]pyridin-2-yl]phenol Chemical compound C1=CC(O)=CC=C1C1=NN(C(NC2CCCC2)=CC=C2)C2=C1C1=CC=NC(NC2CCCC2)=N1 IUEPWZMCLQDBOR-UHFFFAOYSA-N 0.000 claims 1
- FBSUZOMOEAPWGI-UHFFFAOYSA-N 4-[7-(cyclopentylamino)-3-[2-(cyclopropylamino)pyrimidin-4-yl]pyrazolo[1,5-a]pyridin-2-yl]phenol Chemical compound C1=CC(O)=CC=C1C1=NN(C(NC2CCCC2)=CC=C2)C2=C1C1=CC=NC(NC2CC2)=N1 FBSUZOMOEAPWGI-UHFFFAOYSA-N 0.000 claims 1
- GZPOEZSVXJIRAA-UHFFFAOYSA-N 4-[7-(cyclopropylamino)-3-[2-(cyclopropylamino)pyrimidin-4-yl]pyrazolo[1,5-a]pyridin-2-yl]phenol Chemical compound C1=CC(O)=CC=C1C1=NN(C(NC2CC2)=CC=C2)C2=C1C1=CC=NC(NC2CC2)=N1 GZPOEZSVXJIRAA-UHFFFAOYSA-N 0.000 claims 1
- DUDDTXXZIYPHCW-UHFFFAOYSA-N 4-[7-chloro-2-(3-methoxyphenyl)pyrazolo[1,5-a]pyridin-3-yl]-n-cyclopentylpyrimidin-2-amine Chemical compound COC1=CC=CC(C=2C(=C3C=CC=C(Cl)N3N=2)C=2N=C(NC3CCCC3)N=CC=2)=C1 DUDDTXXZIYPHCW-UHFFFAOYSA-N 0.000 claims 1
- OMODOIMGTYNSSP-UHFFFAOYSA-N 4-[7-chloro-2-(3-methylphenyl)pyrazolo[1,5-a]pyridin-3-yl]-n-cyclopentyl-5,6-dimethylpyrimidin-2-amine Chemical compound CC1=CC=CC(C=2C(=C3C=CC=C(Cl)N3N=2)C=2C(=C(C)N=C(NC3CCCC3)N=2)C)=C1 OMODOIMGTYNSSP-UHFFFAOYSA-N 0.000 claims 1
- CTPVGJWGZXELNZ-UHFFFAOYSA-N 4-[[3-[2-(cyclopentylamino)pyrimidin-4-yl]-2-(4-methoxyphenyl)pyrazolo[1,5-a]pyridin-7-yl]amino]butan-1-ol Chemical compound C1=CC(OC)=CC=C1C1=NN(C(NCCCCO)=CC=C2)C2=C1C1=CC=NC(NC2CCCC2)=N1 CTPVGJWGZXELNZ-UHFFFAOYSA-N 0.000 claims 1
- 125000002373 5 membered heterocyclic group Chemical group 0.000 claims 1
- GSTTYBVHTHYNPK-QUSZHGRCSA-N 5-[(3as,4s,6ar)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]-n-[4-[7-(butylamino)-3-[2-(butylamino)pyrimidin-4-yl]pyrazolo[1,5-a]pyridin-2-yl]phenyl]pentanamide Chemical compound CCCCNC1=NC=CC(C2=C3C=CC=C(NCCCC)N3N=C2C=2C=CC(NC(=O)CCCC[C@H]3[C@H]4NC(=O)N[C@H]4CS3)=CC=2)=N1 GSTTYBVHTHYNPK-QUSZHGRCSA-N 0.000 claims 1
- LPGOIVZOZZKUNR-ADXNAEDLSA-N 5-[(3as,4s,6ar)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]-n-[4-[[3-[2-(cyclopentylamino)pyrimidin-4-yl]-2-(4-methoxyphenyl)pyrazolo[1,5-a]pyridin-7-yl]amino]butyl]pentanamide Chemical compound C1=CC(OC)=CC=C1C1=NN(C(NCCCCNC(=O)CCCC[C@H]2[C@H]3NC(=O)N[C@H]3CS2)=CC=C2)C2=C1C1=CC=NC(NC2CCCC2)=N1 LPGOIVZOZZKUNR-ADXNAEDLSA-N 0.000 claims 1
- 125000004070 6 membered heterocyclic group Chemical group 0.000 claims 1
- DHMQDGOQFOQNFH-UHFFFAOYSA-M Aminoacetate Chemical compound NCC([O-])=O DHMQDGOQFOQNFH-UHFFFAOYSA-M 0.000 claims 1
- 208000029433 Herpesviridae infectious disease Diseases 0.000 claims 1
- 229910019142 PO4 Inorganic materials 0.000 claims 1
- 150000001408 amides Chemical class 0.000 claims 1
- 150000001540 azides Chemical class 0.000 claims 1
- 125000006367 bivalent amino carbonyl group Chemical group [H]N([*:1])C([*:2])=O 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 125000004093 cyano group Chemical group *C#N 0.000 claims 1
- 125000001072 heteroaryl group Chemical group 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- URZFGPOTFWRSEP-UHFFFAOYSA-N n'-[3-[2-(cyclopentylamino)pyrimidin-4-yl]-2-(4-methoxyphenyl)pyrazolo[1,5-a]pyridin-7-yl]butane-1,4-diamine Chemical compound C1=CC(OC)=CC=C1C1=NN(C(NCCCCN)=CC=C2)C2=C1C1=CC=NC(NC2CCCC2)=N1 URZFGPOTFWRSEP-UHFFFAOYSA-N 0.000 claims 1
- KYYNKXUDJBNRHP-UHFFFAOYSA-N n-[3-[7-(cyclopentylamino)-3-[2-(cyclopentylamino)pyrimidin-4-yl]pyrazolo[1,5-a]pyridin-2-yl]phenyl]acetamide Chemical compound CC(=O)NC1=CC=CC(C=2C(=C3C=CC=C(NC4CCCC4)N3N=2)C=2N=C(NC3CCCC3)N=CC=2)=C1 KYYNKXUDJBNRHP-UHFFFAOYSA-N 0.000 claims 1
- OFDNOMWOVFJWOC-UHFFFAOYSA-N n-[3-[7-(cyclopentylamino)-3-[2-(cyclopentylamino)pyrimidin-4-yl]pyrazolo[1,5-a]pyridin-2-yl]phenyl]methanesulfonamide Chemical compound CS(=O)(=O)NC1=CC=CC(C=2C(=C3C=CC=C(NC4CCCC4)N3N=2)C=2N=C(NC3CCCC3)N=CC=2)=C1 OFDNOMWOVFJWOC-UHFFFAOYSA-N 0.000 claims 1
- HWQLSJWSPAPOPG-UHFFFAOYSA-N n-[4-[[3-[2-(cyclopentylamino)pyrimidin-4-yl]-2-(4-methoxyphenyl)pyrazolo[1,5-a]pyridin-7-yl]amino]butyl]methanesulfonamide Chemical compound C1=CC(OC)=CC=C1C1=NN(C(NCCCCNS(C)(=O)=O)=CC=C2)C2=C1C1=CC=NC(NC2CCCC2)=N1 HWQLSJWSPAPOPG-UHFFFAOYSA-N 0.000 claims 1
- SZCIIHPOWRLCIH-UHFFFAOYSA-N n-butyl-3-[2-(butylamino)pyrimidin-4-yl]-2-(4-morpholin-4-ylphenyl)pyrazolo[1,5-a]pyridin-7-amine Chemical compound CCCCNC1=NC=CC(C2=C3C=CC=C(NCCCC)N3N=C2C=2C=CC(=CC=2)N2CCOCC2)=N1 SZCIIHPOWRLCIH-UHFFFAOYSA-N 0.000 claims 1
- UGJRRSOZEFGMRQ-UHFFFAOYSA-N n-butyl-3-[2-(butylamino)pyrimidin-4-yl]-2-(4-phenylphenyl)pyrazolo[1,5-a]pyridin-7-amine Chemical compound CCCCNC1=NC=CC(C2=C3C=CC=C(NCCCC)N3N=C2C=2C=CC(=CC=2)C=2C=CC=CC=2)=N1 UGJRRSOZEFGMRQ-UHFFFAOYSA-N 0.000 claims 1
- AJKBXNMWNLJVSK-UHFFFAOYSA-N n-butyl-3-[2-(butylamino)pyrimidin-4-yl]-2-(4-prop-1-en-2-ylphenyl)pyrazolo[1,5-a]pyridin-7-amine Chemical compound CCCCNC1=NC=CC(C2=C3C=CC=C(NCCCC)N3N=C2C=2C=CC(=CC=2)C(C)=C)=N1 AJKBXNMWNLJVSK-UHFFFAOYSA-N 0.000 claims 1
- NXFKTFKZZARTRL-UHFFFAOYSA-N n-butyl-3-[2-(butylamino)pyrimidin-4-yl]-2-[4-(cyclohexylamino)phenyl]pyrazolo[1,5-a]pyridin-7-amine Chemical compound CCCCNC1=NC=CC(C2=C3C=CC=C(NCCCC)N3N=C2C=2C=CC(NC3CCCCC3)=CC=2)=N1 NXFKTFKZZARTRL-UHFFFAOYSA-N 0.000 claims 1
- IPZNCOAQNRRMNG-UHFFFAOYSA-N n-butyl-3-[2-(butylamino)pyrimidin-4-yl]-2-[4-(cyclopropylmethylamino)phenyl]pyrazolo[1,5-a]pyridin-7-amine Chemical compound CCCCNC1=NC=CC(C2=C3C=CC=C(NCCCC)N3N=C2C=2C=CC(NCC3CC3)=CC=2)=N1 IPZNCOAQNRRMNG-UHFFFAOYSA-N 0.000 claims 1
- VLUHLWUXPWMXHA-UHFFFAOYSA-N n-butyl-3-[2-(butylamino)pyrimidin-4-yl]-2-[4-(dimethylamino)phenyl]pyrazolo[1,5-a]pyridin-7-amine Chemical compound CCCCNC1=NC=CC(C2=C3C=CC=C(NCCCC)N3N=C2C=2C=CC(=CC=2)N(C)C)=N1 VLUHLWUXPWMXHA-UHFFFAOYSA-N 0.000 claims 1
- LCPCVBSYINGKBU-UHFFFAOYSA-N n-butyl-3-[2-(butylamino)pyrimidin-4-yl]-2-[4-[(4-methoxyphenyl)methylamino]phenyl]pyrazolo[1,5-a]pyridin-7-amine Chemical compound CCCCNC1=NC=CC(C2=C3C=CC=C(NCCCC)N3N=C2C=2C=CC(NCC=3C=CC(OC)=CC=3)=CC=2)=N1 LCPCVBSYINGKBU-UHFFFAOYSA-N 0.000 claims 1
- FLWPUQVWWOQJCR-UHFFFAOYSA-N n-cyclopentyl-3-[2-(cyclopentylamino)-5,6-dimethylpyrimidin-4-yl]-2-(3-methylphenyl)pyrazolo[1,5-a]pyridin-7-amine Chemical compound CC1=CC=CC(C=2C(=C3C=CC=C(NC4CCCC4)N3N=2)C=2C(=C(C)N=C(NC3CCCC3)N=2)C)=C1 FLWPUQVWWOQJCR-UHFFFAOYSA-N 0.000 claims 1
- XASCGNKLCRYJKI-UHFFFAOYSA-N n-cyclopentyl-3-[2-(cyclopentylamino)pyrimidin-4-yl]-2-(3-fluorophenyl)pyrazolo[1,5-a]pyridin-7-amine Chemical compound FC1=CC=CC(C=2C(=C3C=CC=C(NC4CCCC4)N3N=2)C=2N=C(NC3CCCC3)N=CC=2)=C1 XASCGNKLCRYJKI-UHFFFAOYSA-N 0.000 claims 1
- BZFWCQOKAPYFNZ-UHFFFAOYSA-N n-cyclopentyl-3-[2-(cyclopentylamino)pyrimidin-4-yl]-2-(3-methoxyphenyl)pyrazolo[1,5-a]pyridin-7-amine Chemical compound COC1=CC=CC(C=2C(=C3C=CC=C(NC4CCCC4)N3N=2)C=2N=C(NC3CCCC3)N=CC=2)=C1 BZFWCQOKAPYFNZ-UHFFFAOYSA-N 0.000 claims 1
- XFZVTNMJVGNMEI-UHFFFAOYSA-N n-cyclopentyl-3-[2-(cyclopentylamino)pyrimidin-4-yl]-2-(3-methylphenyl)pyrazolo[1,5-a]pyridin-7-amine Chemical compound CC1=CC=CC(C=2C(=C3C=CC=C(NC4CCCC4)N3N=2)C=2N=C(NC3CCCC3)N=CC=2)=C1 XFZVTNMJVGNMEI-UHFFFAOYSA-N 0.000 claims 1
- QOUDPRBVRCZZAF-UHFFFAOYSA-N n-cyclopentyl-3-[2-(cyclopentylamino)pyrimidin-4-yl]-2-(3-phenylphenyl)pyrazolo[1,5-a]pyridin-7-amine Chemical compound C1CCCC1NC1=NC=CC(C2=C3C=CC=C(NC4CCCC4)N3N=C2C=2C=C(C=CC=2)C=2C=CC=CC=2)=N1 QOUDPRBVRCZZAF-UHFFFAOYSA-N 0.000 claims 1
- UMHKXOZBLQTJHM-UHFFFAOYSA-N n-cyclopentyl-3-[2-(cyclopentylamino)pyrimidin-4-yl]-2-(3-pyridin-4-ylphenyl)pyrazolo[1,5-a]pyridin-7-amine Chemical compound C1CCCC1NC1=NC=CC(C2=C3C=CC=C(NC4CCCC4)N3N=C2C=2C=C(C=CC=2)C=2C=CN=CC=2)=N1 UMHKXOZBLQTJHM-UHFFFAOYSA-N 0.000 claims 1
- RXWCCSNINIJPDY-UHFFFAOYSA-N n-cyclopentyl-3-[2-(cyclopentylamino)pyrimidin-4-yl]-2-(3-thiophen-2-ylphenyl)pyrazolo[1,5-a]pyridin-7-amine Chemical compound C1CCCC1NC1=NC=CC(C2=C3C=CC=C(NC4CCCC4)N3N=C2C=2C=C(C=CC=2)C=2SC=CC=2)=N1 RXWCCSNINIJPDY-UHFFFAOYSA-N 0.000 claims 1
- FMFPUOWQBSQZCG-UHFFFAOYSA-N n-cyclopentyl-3-[2-(cyclopentylamino)pyrimidin-4-yl]-2-(4-methoxyphenyl)pyrazolo[1,5-a]pyridin-7-amine Chemical compound C1=CC(OC)=CC=C1C1=NN(C(NC2CCCC2)=CC=C2)C2=C1C1=CC=NC(NC2CCCC2)=N1 FMFPUOWQBSQZCG-UHFFFAOYSA-N 0.000 claims 1
- NYRPDSRXHRVHKP-UHFFFAOYSA-N n-cyclopentyl-3-[2-(cyclopentylamino)pyrimidin-4-yl]-2-(4-phenoxyphenyl)pyrazolo[1,5-a]pyridin-7-amine Chemical compound C1CCCC1NC1=NC=CC(C2=C3C=CC=C(NC4CCCC4)N3N=C2C=2C=CC(OC=3C=CC=CC=3)=CC=2)=N1 NYRPDSRXHRVHKP-UHFFFAOYSA-N 0.000 claims 1
- LLXJQKCGPYINCG-UHFFFAOYSA-N n-cyclopentyl-3-[2-(cyclopentylamino)pyrimidin-4-yl]-2-(4-prop-2-enoxyphenyl)pyrazolo[1,5-a]pyridin-7-amine Chemical compound C1=CC(OCC=C)=CC=C1C1=NN(C(NC2CCCC2)=CC=C2)C2=C1C1=CC=NC(NC2CCCC2)=N1 LLXJQKCGPYINCG-UHFFFAOYSA-N 0.000 claims 1
- BVLPZDZJOMPDER-UHFFFAOYSA-N n-cyclopentyl-3-[2-(cyclopentylamino)pyrimidin-4-yl]-2-[3-(cyclopropylmethoxy)phenyl]pyrazolo[1,5-a]pyridin-7-amine Chemical compound C1CC1COC(C=1)=CC=CC=1C(C(=C1C=CC=2)C=3N=C(NC4CCCC4)N=CC=3)=NN1C=2NC1CCCC1 BVLPZDZJOMPDER-UHFFFAOYSA-N 0.000 claims 1
- RBJUJGPCYJPFCI-UHFFFAOYSA-N n-cyclopentyl-3-[2-(cyclopentylamino)pyrimidin-4-yl]-2-[3-(trifluoromethyl)phenyl]pyrazolo[1,5-a]pyridin-7-amine Chemical compound FC(F)(F)C1=CC=CC(C=2C(=C3C=CC=C(NC4CCCC4)N3N=2)C=2N=C(NC3CCCC3)N=CC=2)=C1 RBJUJGPCYJPFCI-UHFFFAOYSA-N 0.000 claims 1
- MSYMQUSFKJPTBW-UHFFFAOYSA-N n-cyclopentyl-3-[2-(cyclopentylamino)pyrimidin-4-yl]-2-[4-(2-methylpropoxy)phenyl]pyrazolo[1,5-a]pyridin-7-amine Chemical compound C1=CC(OCC(C)C)=CC=C1C1=NN(C(NC2CCCC2)=CC=C2)C2=C1C1=CC=NC(NC2CCCC2)=N1 MSYMQUSFKJPTBW-UHFFFAOYSA-N 0.000 claims 1
- YSBVWPYUIWKAPA-UHFFFAOYSA-N n-cyclopentyl-3-[2-(cyclopentylamino)pyrimidin-4-yl]-2-[4-(cyclopropylmethoxy)phenyl]pyrazolo[1,5-a]pyridin-7-amine Chemical compound C1CC1COC(C=C1)=CC=C1C(C(=C1C=CC=2)C=3N=C(NC4CCCC4)N=CC=3)=NN1C=2NC1CCCC1 YSBVWPYUIWKAPA-UHFFFAOYSA-N 0.000 claims 1
- DNJDAOUZXFKWRM-UHFFFAOYSA-N n-cyclopentyl-3-[2-(cyclopentylamino)pyrimidin-4-yl]-2-phenylpyrazolo[1,5-a]pyridin-7-amine Chemical compound C1CCCC1NC1=NC=CC(C2=C3C=CC=C(NC4CCCC4)N3N=C2C=2C=CC=CC=2)=N1 DNJDAOUZXFKWRM-UHFFFAOYSA-N 0.000 claims 1
- ZRTFWADTSDLSRT-UHFFFAOYSA-N n-cyclopentyl-3-[2-(cyclopropylamino)pyrimidin-4-yl]-2-(3-fluorophenyl)pyrazolo[1,5-a]pyridin-7-amine Chemical compound FC1=CC=CC(C=2C(=C3C=CC=C(NC4CCCC4)N3N=2)C=2N=C(NC3CC3)N=CC=2)=C1 ZRTFWADTSDLSRT-UHFFFAOYSA-N 0.000 claims 1
- KSKOOGUWUXDAIN-UHFFFAOYSA-N n-cyclopentyl-3-[2-(cyclopropylamino)pyrimidin-4-yl]-2-(4-methoxyphenyl)pyrazolo[1,5-a]pyridin-7-amine Chemical compound C1=CC(OC)=CC=C1C1=NN(C(NC2CCCC2)=CC=C2)C2=C1C1=CC=NC(NC2CC2)=N1 KSKOOGUWUXDAIN-UHFFFAOYSA-N 0.000 claims 1
- ZBPANWLHZWXUOF-UHFFFAOYSA-N n-cyclopentyl-4-[2-(3-fluorophenyl)-7-morpholin-4-ylpyrazolo[1,5-a]pyridin-3-yl]pyrimidin-2-amine Chemical compound FC1=CC=CC(C=2C(=C3C=CC=C(N3N=2)N2CCOCC2)C=2N=C(NC3CCCC3)N=CC=2)=C1 ZBPANWLHZWXUOF-UHFFFAOYSA-N 0.000 claims 1
- YFDVTDKCHFIORO-UHFFFAOYSA-N n-cyclopentyl-4-[2-(3-phenylphenyl)-7-pyrrolidin-1-ylpyrazolo[1,5-a]pyridin-3-yl]pyrimidin-2-amine Chemical compound C1CCCC1NC1=NC=CC(C2=C3C=CC=C(N3N=C2C=2C=C(C=CC=2)C=2C=CC=CC=2)N2CCCC2)=N1 YFDVTDKCHFIORO-UHFFFAOYSA-N 0.000 claims 1
- DCORZUCVQOXEOG-UHFFFAOYSA-N n-cyclopentyl-4-[2-(4-methoxyphenyl)-7-morpholin-4-ylpyrazolo[1,5-a]pyridin-3-yl]pyrimidin-2-amine Chemical compound C1=CC(OC)=CC=C1C1=NN(C(=CC=C2)N3CCOCC3)C2=C1C1=CC=NC(NC2CCCC2)=N1 DCORZUCVQOXEOG-UHFFFAOYSA-N 0.000 claims 1
- GJKBRPIYUIZXFG-UHFFFAOYSA-N n-cyclopentyl-4-[2-(4-methoxyphenyl)-7-pyrrolidin-1-ylpyrazolo[1,5-a]pyridin-3-yl]pyrimidin-2-amine Chemical compound C1=CC(OC)=CC=C1C1=NN(C(=CC=C2)N3CCCC3)C2=C1C1=CC=NC(NC2CCCC2)=N1 GJKBRPIYUIZXFG-UHFFFAOYSA-N 0.000 claims 1
- FYDOYXKIRVHWEC-UHFFFAOYSA-N n-cyclopropyl-3-[2-(cyclopropylamino)pyrimidin-4-yl]-2-(4-methoxyphenyl)pyrazolo[1,5-a]pyridin-7-amine Chemical compound C1=CC(OC)=CC=C1C1=NN(C(NC2CC2)=CC=C2)C2=C1C1=CC=NC(NC2CC2)=N1 FYDOYXKIRVHWEC-UHFFFAOYSA-N 0.000 claims 1
- XOCAXFBXUXTLAV-UHFFFAOYSA-N n-cyclopropyl-3-[2-(cyclopropylamino)pyrimidin-4-yl]-2-[4-(cyclopropylmethoxy)phenyl]pyrazolo[1,5-a]pyridin-7-amine Chemical compound C1CC1COC(C=C1)=CC=C1C(C(=C1C=CC=2)C=3N=C(NC4CC4)N=CC=3)=NN1C=2NC1CC1 XOCAXFBXUXTLAV-UHFFFAOYSA-N 0.000 claims 1
- NOAMJCVNUJMSBD-UHFFFAOYSA-N n-cyclopropyl-4-[2-(4-methoxyphenyl)-7-morpholin-4-ylpyrazolo[1,5-a]pyridin-3-yl]pyrimidin-2-amine Chemical compound C1=CC(OC)=CC=C1C1=NN(C(=CC=C2)N3CCOCC3)C2=C1C1=CC=NC(NC2CC2)=N1 NOAMJCVNUJMSBD-UHFFFAOYSA-N 0.000 claims 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000010452 phosphate Substances 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
- UZYOKGJMTACFLK-UHFFFAOYSA-N tert-butyl n-[n'-[4-[[3-[2-(cyclopentylamino)pyrimidin-4-yl]-2-(4-methoxyphenyl)pyrazolo[1,5-a]pyridin-7-yl]amino]butyl]-n-[(2-methylpropan-2-yl)oxycarbonyl]carbamimidoyl]carbamate Chemical compound C1=CC(OC)=CC=C1C1=NN(C(NCCCCNC(NC(=O)OC(C)(C)C)=NC(=O)OC(C)(C)C)=CC=C2)C2=C1C1=CC=NC(NC2CCCC2)=N1 UZYOKGJMTACFLK-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27429701P | 2001-03-08 | 2001-03-08 | |
| PCT/US2002/006552 WO2002072581A2 (en) | 2001-03-08 | 2002-03-05 | Pyrazolopyriadine derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004529119A JP2004529119A (ja) | 2004-09-24 |
| JP2004529119A5 true JP2004529119A5 (enExample) | 2005-07-07 |
Family
ID=23047621
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002571497A Ceased JP2004529119A (ja) | 2001-03-08 | 2002-03-05 | ピラゾロピリジン誘導体 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US7153855B2 (enExample) |
| EP (1) | EP1366048B1 (enExample) |
| JP (1) | JP2004529119A (enExample) |
| AT (1) | ATE274515T1 (enExample) |
| AU (1) | AU2002248531A1 (enExample) |
| DE (1) | DE60201074T2 (enExample) |
| ES (1) | ES2227451T3 (enExample) |
| WO (1) | WO2002072581A2 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004525150A (ja) * | 2001-03-30 | 2004-08-19 | スミスクライン ビーチャム コーポレーション | 治療用化合物としてのピラゾロピリジン類の使用 |
| ATE364043T1 (de) * | 2001-09-07 | 2007-06-15 | Smithkline Beecham Corp | Pyrazolo-pyridine für die behandlung von herpes- ansteckungen |
| EP1485385B1 (en) | 2002-03-07 | 2005-08-17 | SmithKline Beecham Corporation | Pyrazolopyrimidine and pyrazolotriazine derivatives and pharmaceutical compositions containing them |
| WO2004033454A1 (en) * | 2002-10-03 | 2004-04-22 | Smithkline Beecham Corporation | Therapeutic compounds based on pyrazolopyridine derivatives |
| UA103319C2 (en) | 2008-05-06 | 2013-10-10 | Глаксосмитклайн Ллк | Thiazole- and oxazole-benzene sulfonamide compounds |
| ES2422263T3 (es) * | 2008-12-19 | 2013-09-10 | Nerviano Medical Sciences Srl | Pirazoles bicíclicos como inhibidores de la proteinquinasa |
| BRPI1011058A2 (pt) * | 2009-05-19 | 2015-08-25 | Dow Agrosciences Llc | Compostos e metodos controlar fungos |
| EP2402336A1 (en) * | 2010-06-29 | 2012-01-04 | Basf Se | Pyrazolopyridine compounds |
| PL2763993T3 (pl) * | 2011-10-06 | 2017-09-29 | Bayer Intellectual Property Gmbh | Heterocyklilopiry(mi)dynylopirazol |
| MX389591B (es) | 2014-08-29 | 2025-03-20 | Tes Pharma S R L | INHIBIDORES DE ACIDO A-AMINO-ß-CARBOXIMUCONICO SEMIALDEHIDO DESCARBOXILASA |
| US20220296595A1 (en) | 2019-05-05 | 2022-09-22 | Qilu Regor Therapeutics Inc. | Cdk inhibitors |
Family Cites Families (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0151962A3 (en) | 1984-01-25 | 1985-10-02 | Beecham Group Plc | Pyrazolopyridine derivatives |
| GB8404584D0 (en) | 1984-02-22 | 1984-03-28 | Beecham Group Plc | Compounds |
| GB8404586D0 (en) | 1984-02-22 | 1984-03-28 | Beecham Group Plc | Compounds |
| US5002941A (en) | 1985-12-12 | 1991-03-26 | Smithkline Beecham Corporation | Pyrrolo(1,2-a)imidazole and imidazo(1,2-a)pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors |
| US4925849A (en) | 1987-06-15 | 1990-05-15 | Fujisawa Pharmaceutical Company, Ltd. | Pharmaceutically useful pyrazolopyridines |
| US5155114A (en) | 1989-01-23 | 1992-10-13 | Fujisawa Pharmaceutical Company, Ltd. | Method of treatment using pyrazolopyridine compound |
| GB8901423D0 (en) | 1989-01-23 | 1989-03-15 | Fujisawa Pharmaceutical Co | Pyrazolopyridine compound and processes for preparation thereof |
| WO1991000092A1 (en) | 1989-06-13 | 1991-01-10 | Smithkline Beecham Corporation | Inhibition of interleukin-1 and tumor necrosis factor production by monocytes and/or macrophages |
| AU622330B2 (en) | 1989-06-23 | 1992-04-02 | Takeda Chemical Industries Ltd. | Condensed heterocyclic compounds having a nitrogen atom in the bridgehead for use as fungicides |
| CA2084290A1 (en) | 1990-06-12 | 1991-12-13 | Jerry L. Adams | Inhibition of 5-lipoxygenase and cyclooxygenase pathway mediated diseases |
| GB9015764D0 (en) | 1990-07-18 | 1990-09-05 | Fujisawa Pharmaceutical Co | Pyrazolopyridine compound and processes for preparation thereof |
| DE4102340A1 (de) * | 1991-01-26 | 1992-07-30 | Bayer Ag | Lichtleitfasern und verfahren zu ihrer herstellung |
| ATE211384T1 (de) | 1991-01-29 | 2002-01-15 | Fujisawa Pharmaceutical Co | Verwendung von adenosinantagonisten zur vorbeugung und behandlung von pankreatitis und ulcera |
| GB9107513D0 (en) | 1991-04-10 | 1991-05-29 | Fujisawa Pharmaceutical Co | Pyrazolopyridine compound and processes for preparation thereof |
| US5300478A (en) | 1993-01-28 | 1994-04-05 | Zeneca Limited | Substituted fused pyrazolo compounds |
| US5474995A (en) | 1993-06-24 | 1995-12-12 | Merck Frosst Canada, Inc. | Phenyl heterocycles as cox-2 inhibitors |
| AU694157B2 (en) | 1993-12-29 | 1998-07-16 | Fujisawa Pharmaceutical Co., Ltd. | Pyrazolopyridine adenosine antagonists |
| US5521213A (en) | 1994-08-29 | 1996-05-28 | Merck Frosst Canada, Inc. | Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2 |
| US5552422A (en) | 1995-01-11 | 1996-09-03 | Merck Frosst Canada, Inc. | Aryl substituted 5,5 fused aromatic nitrogen compounds as anti-inflammatory agents |
| EA199700209A1 (ru) | 1995-04-04 | 1998-04-30 | Глаксо Груп Лимитед | ПРОИЗВОДНЫЕ ИМИДАЗО[1,2-a]ПИРИДИНА |
| US6342510B1 (en) | 1995-06-12 | 2002-01-29 | G. D. Searle & Co. | Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitors and a leukotriene B4 receptor antagonist |
| JPH11507670A (ja) | 1995-06-12 | 1999-07-06 | ジー．ディー．サール アンド カンパニー | シクロオキシゲナーゼ−２インヒビターと５−リポキシゲナーゼインヒビターの組合せによる炎症と炎症関連疾患の治療 |
| US5700816A (en) | 1995-06-12 | 1997-12-23 | Isakson; Peter C. | Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a leukotriene A4 hydrolase inhibitor |
| FR2757059B1 (fr) | 1996-12-12 | 1999-01-29 | Rhone Poulenc Rorer Sa | Nouvelle application therapeutique des derives du pyrrole |
| FR2757166B1 (fr) | 1996-12-12 | 1999-01-29 | Rhone Poulenc Rorer Sa | Derives du pyrrole, leur preparation et les compositions pharmaceutiques qui les contiennent |
| US20020156104A1 (en) | 1997-06-13 | 2002-10-24 | Jerry L. Adams | Novel pyrazole and pyrazoline substituted compounds |
| EP1369421B1 (en) | 1997-09-05 | 2004-11-03 | Glaxo Group Limited | Pharmaceutical compositions comprising 2,3-Diaryl-pyrazolo[1,5-B]pyridazine derivatives |
| CA2331878A1 (en) | 1998-05-14 | 1999-11-18 | G.D. Searle & Co. | 1,5-diaryl substituted pyrazoles as p38 kinase inhibitors |
| US6245789B1 (en) | 1998-05-19 | 2001-06-12 | The Procter & Gamble Company | HIV and viral treatment |
| FR2779724B1 (fr) * | 1998-06-10 | 2001-04-20 | Rhone Poulenc Rorer Sa | Derives du pyrrole, leur preparation et les compositions pharmaceutiques qui les contiennent |
| WO2000026216A1 (en) | 1998-11-03 | 2000-05-11 | Glaxo Group Limited | Pyrazolopyridine derivatives as selective cox-2 inhibitors |
| AU2661400A (en) | 1999-02-27 | 2000-09-21 | Glaxo Group Limited | Pyrazolopyridines |
| HRP20010934A2 (en) | 1999-06-28 | 2003-06-30 | Janssen Pharmaceutica Nv | Respiratory syncytial virus replication inhibitors |
| GB9919778D0 (en) | 1999-08-21 | 1999-10-27 | Zeneca Ltd | Chemical compounds |
| PE20020506A1 (es) | 2000-08-22 | 2002-07-09 | Glaxo Group Ltd | Derivados de pirazol fusionados como inhibidores de la proteina cinasa |
| AUPQ969800A0 (en) | 2000-08-28 | 2000-09-21 | Fujisawa Pharmaceutical Co., Ltd. | Pyrazolopyridine compound and pharmaceutical use thereof |
| EP1377573B1 (en) | 2000-12-15 | 2005-07-27 | Glaxo Group Limited | Pyrazolopyridine derivatives |
| EP1341788B1 (en) | 2000-12-15 | 2005-08-10 | Glaxo Group Limited | Pyrazolopyridines |
| GB0103926D0 (en) | 2001-02-17 | 2001-04-04 | Astrazeneca Ab | Chemical compounds |
| AU2002305143A1 (en) | 2001-04-27 | 2002-11-11 | Smithkline Beecham Corporation | Pyrazolo'1,5-a!pyridine derivatives |
| CA2450555A1 (en) | 2001-06-25 | 2003-01-03 | Merck & Co., Inc. | (pyrimidyl)(phenyl)substituted fused heteroaryl p38 inhibiting and pkg kinase inhibiting compounds |
-
2002
- 2002-03-05 US US10/468,729 patent/US7153855B2/en not_active Expired - Fee Related
- 2002-03-05 AT AT02717537T patent/ATE274515T1/de not_active IP Right Cessation
- 2002-03-05 WO PCT/US2002/006552 patent/WO2002072581A2/en not_active Ceased
- 2002-03-05 ES ES02717537T patent/ES2227451T3/es not_active Expired - Lifetime
- 2002-03-05 JP JP2002571497A patent/JP2004529119A/ja not_active Ceased
- 2002-03-05 AU AU2002248531A patent/AU2002248531A1/en not_active Abandoned
- 2002-03-05 EP EP02717537A patent/EP1366048B1/en not_active Expired - Lifetime
- 2002-03-05 DE DE60201074T patent/DE60201074T2/de not_active Expired - Fee Related
-
2006
- 2006-08-30 US US11/468,319 patent/US20060293344A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004527560A5 (enExample) | ||
| JP2004529119A5 (enExample) | ||
| JP2005500315A5 (enExample) | ||
| JP2004529926A5 (enExample) | ||
| RU2412943C2 (ru) | ПРОИЗВОДНЫЕ АЦЕТИЛЕНИЛ-ПИРАЗОЛО-ПИРИМИДИНА В КАЧЕСТВЕ АНТАГОНИСТОВ mGluR2 | |
| JP2020504136A5 (enExample) | ||
| HRP20160112T1 (hr) | HETEROARIL SUPSTITUIRANI PIROLO[2,3-b]PIRIDINI I PIROLO[2,3-b]PIRIMIDINI KAO INHIBITORI JANUS KINAZE | |
| SI3106463T1 (en) | Compounds of substituted pyrazolo (1,5-) pyrimidine as inhibitors of TRK kinase | |
| JP2013500247A5 (enExample) | ||
| JP2003525279A5 (enExample) | ||
| RU2004106783A (ru) | Производные 4-амино-6-фенилпирроло[2, 3] пиримидина | |
| JP2010513447A5 (enExample) | ||
| JP2004517087A5 (enExample) | ||
| RU2015117949A (ru) | Ингибиторы тирозинкиназы брутона | |
| IL295487A (en) | gcn2 modulator compounds | |
| JP2008509187A5 (enExample) | ||
| JP2009519340A5 (enExample) | ||
| JP2005507380A5 (enExample) | ||
| JP2005524609A5 (enExample) | ||
| JP2008516973A5 (enExample) | ||
| RU2003124651A (ru) | Производные триазоло[4,5-d]пиримидина и их применение в качестве антагонистов пуринергического рецептора | |
| JP2016506387A5 (enExample) | ||
| JP2006515604A5 (enExample) | ||
| HRP20251042T1 (hr) | Nova kombinacija aktivnih sredstava za liječenje progresivnih intersticijskih bolesti pluća s fibroznim promjenama (pf-ild) | |
| RU2008142841A (ru) | СОЕДИНЕНИЯ ИМИДАЗО-[1, 2-b]-ПИРИДАЗИНА (ВАРИАНТЫ), СПОСОБ ПОЛУЧЕНИЯ СОЕДИНЕНИЙ ИМИДАЗО-[1, 2-b]-ПИРИДАЗИНА (ВАРИАНТЫ), ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ И ЛЕКАРСТВЕННОЕ СРЕДСТВО ДЛЯ ЛЕЧЕНИЯ И/ИЛИ ПРЕДУПРЕЖДЕНИЯ ЗАБОЛЕВАНИЙ, СВЯЗАННЫХ С МОДУЛЯЦИЕЙ ГАМКА РЕЦЕПТОРОВ |